Novoray Corporation

SHSE:688300 Rapport sur les actions

Capitalisation boursière : CN¥9.7b

Novoray Croissance future

Future contrôle des critères 5/6

Novoray devrait augmenter ses bénéfices et son chiffre d'affaires de 27.3% et de 22.7% par an respectivement. Le BPA devrait croître de de 27% par an. Le rendement des capitaux propres devrait être 19.6% dans 3 ans.

Informations clés

27.3%

Taux de croissance des bénéfices

27.0%

Taux de croissance du BPA

Chemicals croissance des bénéfices39.6%
Taux de croissance des recettes22.7%
Rendement futur des capitaux propres19.6%
Couverture par les analystes

Low

Dernière mise à jour23 Oct 2024

Mises à jour récentes de la croissance future

Earnings Miss: Novoray Corporation Missed EPS By 8.5% And Analysts Are Revising Their Forecasts

Mar 28
Earnings Miss: Novoray Corporation Missed EPS By 8.5% And Analysts Are Revising Their Forecasts

Recent updates

Market Participants Recognise Novoray Corporation's (SHSE:688300) Earnings Pushing Shares 34% Higher

Oct 18
Market Participants Recognise Novoray Corporation's (SHSE:688300) Earnings Pushing Shares 34% Higher

These 4 Measures Indicate That Novoray (SHSE:688300) Is Using Debt Safely

Oct 16
These 4 Measures Indicate That Novoray (SHSE:688300) Is Using Debt Safely

What Does Novoray Corporation's (SHSE:688300) Share Price Indicate?

Sep 26
What Does Novoray Corporation's (SHSE:688300) Share Price Indicate?

If EPS Growth Is Important To You, Novoray (SHSE:688300) Presents An Opportunity

Aug 20
If EPS Growth Is Important To You, Novoray (SHSE:688300) Presents An Opportunity

Novoray's (SHSE:688300) Returns On Capital Not Reflecting Well On The Business

Jul 29
Novoray's (SHSE:688300) Returns On Capital Not Reflecting Well On The Business

What Novoray Corporation's (SHSE:688300) P/E Is Not Telling You

Jul 13
What Novoray Corporation's (SHSE:688300) P/E Is Not Telling You

Why Novoray Corporation (SHSE:688300) Could Be Worth Watching

Jun 19
Why Novoray Corporation (SHSE:688300) Could Be Worth Watching

If EPS Growth Is Important To You, Novoray (SHSE:688300) Presents An Opportunity

May 13
If EPS Growth Is Important To You, Novoray (SHSE:688300) Presents An Opportunity

Does Novoray (SHSE:688300) Have A Healthy Balance Sheet?

Apr 23
Does Novoray (SHSE:688300) Have A Healthy Balance Sheet?

Novoray's (SHSE:688300) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 01
Novoray's (SHSE:688300) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Earnings Miss: Novoray Corporation Missed EPS By 8.5% And Analysts Are Revising Their Forecasts

Mar 28
Earnings Miss: Novoray Corporation Missed EPS By 8.5% And Analysts Are Revising Their Forecasts

Subdued Growth No Barrier To Novoray Corporation (SHSE:688300) With Shares Advancing 28%

Mar 01
Subdued Growth No Barrier To Novoray Corporation (SHSE:688300) With Shares Advancing 28%

When Should You Buy Novoray Corporation (SHSE:688300)?

Feb 27
When Should You Buy Novoray Corporation (SHSE:688300)?

Prévisions de croissance des bénéfices et des revenus

SHSE:688300 - Estimations futures des analystes et données financières antérieures (CNY Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/20261,461420N/A3585
12/31/20251,182329N/A2825
12/31/2024935245N/A1765
9/30/2024895234167248N/A
6/30/2024841218164236N/A
3/31/2024769197137189N/A
12/31/2023712174194247N/A
9/30/2023685182139203N/A
6/30/2023625169156248N/A
3/31/2023630174130277N/A
12/31/202266218886241N/A
9/30/202265717524213N/A
6/30/2022686186-47161N/A
3/31/2022663179-64117N/A
12/31/2021625173-55153N/A
9/30/2021581169-94117N/A
6/30/2021522147-42135N/A
3/31/2021473130-57104N/A
12/31/2020404111-3490N/A
9/30/2020367921998N/A
6/30/2020341822995N/A
3/31/20203217827100N/A
12/31/2019315752081N/A
9/30/2019298694397N/A
6/30/2019292672370N/A
3/31/2019277602953N/A
12/31/2018278583056N/A
9/30/201826454834N/A
6/30/201824950N/A12N/A
3/31/201823046N/A9N/A
12/31/201721142N/A6N/A
9/30/201719341N/A17N/A
6/30/201717639N/A27N/A
3/31/201716536N/A22N/A
12/31/201615433N/A18N/A
9/30/201614327N/AN/AN/A
6/30/201613220N/A16N/A
3/31/201612719N/A12N/A
12/31/201512218N/A7N/A
9/30/201512119N/A3N/A
6/30/201513220N/A9N/A
3/31/201513119N/A16N/A
12/31/201412519N/A17N/A
12/31/201312014N/A28N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de 688300 ( 27.3% par an) est supérieure au taux d'épargne ( 2.8% ).

Bénéfices vs marché: Les bénéfices de 688300 ( 27.3% par an) devraient croître plus rapidement que le marché CN ( 26.1% par an).

Croissance élevée des bénéfices: Les bénéfices de 688300 devraient augmenter de manière significative au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de 688300 ( 22.7% par an) devrait croître plus rapidement que le marché CN ( 13.8% par an).

Croissance élevée des revenus: Le chiffre d'affaires de 688300 ( 22.7% par an) devrait croître plus rapidement que 20% par an.


Prévisions de croissance du bénéfice par action


Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de 688300 devrait être faible dans 3 ans ( 19.6 %).


Découvrir les entreprises en croissance